UNSPSC 51351909: Promegestone

This classification denotes a steroid compound with the molecular formula C22H30O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9XE0V2SQYX, chemically known as 17alpha-methyl-1,7-propionylestra-4,9-dien-3-one but generally known as promegestone, which bears US NIH Compound Identifier 36709. European Medicines Agency schedules Promegestone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10086MIG.

UNSPSC 51351909 Promegestone, a Commodity code, identifies a synthetic progestin pharmaceutical product that state and local governments procure through health and human services agencies, correctional facilities, and public health departments. Promegestone is a progesterone receptor agonist used in hormone replacement therapy and other clinical applications; state and local buyers source this specific active pharmaceutical ingredient or finished pharmaceutical formulations containing it for use in public health programs, inmate medical care, and clinical settings operated by state health authorities. The issuing bodies soliciting under this code typically include state departments of health, state correctional agencies, and county health departments that maintain formularies or operate integrated pharmacy systems.

The source provided contains no recent state or local contract opportunities tagged to UNSPSC 51351909 Promegestone. Without posted solicitations, the geographic distribution and current market activity under this code cannot be characterized from available procurement records.